1 |
Wang J, Chen G, Liu N, Han X, Zhao F, Zhang L, Chen P. Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes. Advances in Colloid and Interface Science 2022. [DOI: 10.1016/j.cis.2022.102638] [Reference Citation Analysis]
|
2 |
Lu L, Xu Q, Wang J, Wu S, Luo Z, Lu W. Drug Nanocrystals for Active Tumor-Targeted Drug Delivery. Pharmaceutics 2022;14:797. [DOI: 10.3390/pharmaceutics14040797] [Reference Citation Analysis]
|
3 |
Tian M, Xin X, Wu R, Guan W, Zhou W. Advances in Intelligent-Responsive Nanocarriers for Cancer Therapy. Pharmacol Res 2022;:106184. [PMID: 35301111 DOI: 10.1016/j.phrs.2022.106184] [Reference Citation Analysis]
|
4 |
Souri M, Soltani M, Kashkooli FM, Shahvandi MK, Chiani M, Shariati FS, Mehrabi MR, Munn LL. Towards principled design of cancer nanomedicine to accelerate clinical translation. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100208] [Reference Citation Analysis]
|
5 |
Wang X, Zhang W. The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis. J Control Release 2022:S0168-3659(22)00189-4. [PMID: 35367478 DOI: 10.1016/j.jconrel.2022.03.056] [Reference Citation Analysis]
|
6 |
Andrada HE, Venosta L, Jacobo SE, Fernando Silva O, Darío Falcone R, Bercoff PG. Highly stable nanostructured magnetic vesicles as doxorubicin carriers for field‐assisted therapies. ChemNanoMat. [DOI: 10.1002/cnma.202100409] [Reference Citation Analysis]
|
7 |
Cao W, Jin M, Yang K, Chen B, Xiong M, Li X, Cao G. Fenton/Fenton-like metal-based nanomaterials combine with oxidase for synergistic tumor therapy. J Nanobiotechnology 2021;19:325. [PMID: 34656118 DOI: 10.1186/s12951-021-01074-1] [Reference Citation Analysis]
|